Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | ritodrine | 688570 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | ritodrine | 688570 | drug-path |
| Asthma | R-HSA-444620 | map05310 | ritodrine | 688570 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | ritodrine | 688570 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | ritodrine | 688570 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ritodrine | 688570 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | ritodrine | 688570 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ritodrine | 688570 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | ritodrine | 688570 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | ritodrine | 688570 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | ritodrine | 688570 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ritodrine | 688570 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | ritodrine | 688570 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | guanfacine | 3519 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | guanfacine | 3519 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | guanfacine | 3519 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | guanfacine | 3519 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | guanfacine | 3519 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | guanfacine | 3519 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | guanfacine | 3519 | drug-path |